TABLE 4.
Estimated differences in continuous outcomes by quartiles of baseline mean striatal binding
Number of Subjects | P Value for Trend | Estimated Differences (95% CI)
|
|||||
---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | ||||
MMSE | ↓ | 491 | 0.0067 | −0.9 (−1.6, −0.3) | −0.3 (−0.9, 0.3) | −0.2 (−0.8, 0.4) | 0 |
MoCA | ↓ | 489 | <0.0001 | −1.9 (−2.9, −1.0) | −0.6 (−1.5, 0.3) | −0.1 (−0.9, 0.8) | 0 |
UPDRS motor | ↑ | 487 | <0.0001 | 7.1 (4.1, 10.1) | 2.1 (−0.8, 4.9) | 1.7 (−1.1, 4.4) | 0 |
UPDRS ADL | ↑ | 489 | <0.0001 | 3.3 (1.7, 4.9) | 1.3 (−0.2, 2.9) | 0.3 (−1.2, 1.7) | 0 |
Parameter estimates (95% CIs) from separate multiple regressions adjusted for age, gender, duration of disease, and PreCEPT study treatment, as well as for use of DAAs and/or L-dopa at most recent visit (or assessment). Arrow indicates direction of worsening. Mean values for quartiles are shown in Table 2. The highest quartile is the reference category.